(Alliance News) - London's FTSE 100 opened a touch higher on Friday, adding to its weekly gains, with gold miners among those in the green in early trade, though AstraZeneca fell after a downbeat broker assessment. Read More
(Alliance News) - London's FTSE 100 is called to open a touch higher, with more strong trade in New York adding some cautious confidence to markets on this side of the Atlantic. Read More
(Alliance News) - London's FTSE 100 underperformed European peers, but headed into Wednesday afternoon just about in the green as a US inflation reading looms. Read More
(Alliance News) - European stocks slid on Tuesday with a double-digit fall in BMW knocking Frankfurt and declines for index heavyweights AstraZeneca, BP and Shell weighing on London. Read More
(Alliance News) - London's FTSE 100 traded lower on Tuesday, underperforming European peers, as index heavyweights in pharmaceuticals, mining, and oil were in the red. Read More
(Alliance News) - AstraZeneca PLC shares weakened on Tuesday morning, after tepid results from a lung cancer drug trial left investors fretting about regulatory approval chances. Read More
(Alliance News) - London's FTSE 100 started the day on the back foot, returning some of its advance from the start of the week, ahead of US data and a presidential debate across the Atlantic. Read More
(Alliance News) - Stocks faded into the close on Thursday to end in the red weighed by a drop in index heavyweight AstraZeneca on a day of mixed news for blue-chips. Read More
(Alliance News) - Several employees of multinational pharmaceutical firm AstraZeneca PLC are under investigation in China, the firm told AFP Thursday, after a report said they were being questioned about potentially illegal data collection and drug imports. Read More
(Alliance News) - AstraZeneca PLC on Tuesday announced that China's National Medical Products Association has approved benralizumab to treat patients aged 12 and older with severe eosinophilic asthma. Read More
(Alliance News) - Stocks in London are called to open lower on Tuesday, as investors look ahead to a key inflation reading from the eurozone. Read More
(Alliance News) - Daiichi Sankyo Co Ltd on Monday announced positive updates for Enhertu, with the cancer drug receiving support from US and European regulators. Read More
(Alliance News) - AstraZeneca PLC on Friday said Imfinzi has been approved in the US for the treatment of resectable non-small cell lung cancer before and after surgery. Read More
(Alliance News) - AstraZeneca PLC on Thursday said Imfinzi has been granted priority review and breakthrough therapy designation for patients with limited-stage small cell lung cancer in the US. Read More
(Alliance News) - Stock prices in London opened a mixed bag on Thursday, with the FTSE 100 in the green but others trailing behind, after data showed no monthly growth in the UK economy. Read More
(Alliance News) - Stock prices in London were higher at midday on Wednesday, as the market remained optimistic following a UK CPI print in the morning, and ahead of one from the US later in the afternoon. Read More
